Thuy Le
Thuy Le
Dr
My research interest is in reducing disease burden, improving diagnostics and treatment of HIV-associated infections through epidemiology, laboratory technologies and clinical trials. My major disease areas of interest are HIV-associated opportunistic infections, specifically Penicillium marneffei infection, HIV drug resistance, and HIV-HCV coinfection. I collaborate closely with major hospitals providing HIV care throughout Vietnam. Currently I am the Principal Investigator of 2 ongoing multi-center clinical trials, one comparing amphotericin B and itraconazole in the treatment of HIV-associated penicilliosis, the other to evaluate the safety of raltegravir compared to efavirenz in HIV-HCV coinfection. I also lead and collaborate on studies to understand disease epidemiology, identifying risk factors for infections, and improving diagnostics and treatment of penicilliosis.
Recent publications
-
Clinical features of three patients with paradoxical immune reconstitution inflammatory syndrome associated with Talaromyces marneffei infection.
Journal article
Thanh NT. et al, (2018), Med Mycol Case Rep, 19, 33 - 37
-
Fungal infections in HIV/AIDS.
Journal article
Limper AH. et al, (2017), Lancet Infect Dis, 17, e334 - e343
-
Itraconazole and antiretroviral therapy: strategies for empirical dosing - Author's reply.
Other
Le T. et al, (2017), Lancet Infect Dis, 17, 1123 - 1124
-
Itraconazole or Amphotericin B for Talaromycosis.
Journal article
Le T. et al, (2017), N Engl J Med, 377
-
New diagnostic tools in endemic mycoses
Other
Le T. and Pasqualotto AC., (2017), MYCOSES, 60, 14 - 14